Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Enliven Therapeutics (ELVN) Q2 2021 Earnings
ELVN
6
Aug
Expected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-2.96
-2.16
-1.36
-0.56
Details
Expected EPS
-0.9109
Actual EPS
-2.96
Surprise EPS
-2.05
Surprise Percent
+224.95%
Description
Enliven Therapeutics (ELVN) has reported earnings of -2.96 per share for Q2 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login